Oramed Pharmaceuticals
ORMP
#8928
Rank
HK$0.74 B
Marketcap
HK$18.49
Share price
0.42%
Change (1 day)
9.63%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): HK$0.19 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of HK$55.36 Million, an increase over its 2022 earnings that were of -HK$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$0.19 B247.89%
2023 HK$55.36 M-119.45%
2022 -HK$0.29 Billion39.17%
2021 -HK$0.21 Billion73.93%
2020 -HK$0.12 Billion18.53%
2019 -HK$99.2 Million-16.62%
2018 -HK$0.12 Billion38.32%
2017 -HK$86.01 Million12.51%
2016 -HK$76.45 Million25.01%
2015 -HK$61.16 Million18.18%
2014 -HK$51.75 Million39.72%
2013 -HK$37.04 Million46.4%
2012 -HK$25.3 Million128.32%
2011 -HK$11.09 Million-51.47%
2010 -HK$22.84 Million35.21%
2009 -HK$16.89 Million
2007 -HK$26.56 Million607.04%
2006 -HK$3.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$3.86 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$138.64 B 72,308.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
HK$57.56 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
HK$0.11 B-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-HK$1.69 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA